Production of meiosis-activating sterols from metabolically engineered yeast.
Meiosis-activating sterols (MAS), a class of potent regulators of reproductive processes, are difficult to obtain by chemical synthesis or isolation from natural sources. We demonstrate the development of metabolically engineered strains of Saccharomyces cerevisiae that accumulate MAS as the predominant sterol product. Homologous recombination was used to construct an erg24Delta erg25Delta hem1Delta mutant RXY4.3, which lacked sterol Delta14 reductase, C-4 oxidase, and delta-aminolevulinate synthase. The HEM1 deletion allowed sterol import and rendered RXY4.3 viable under aerobic conditions. This mutant accumulated 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol (FF-MAS), and a similar erg25Delta hem1Delta mutant produced 4,4-dimethyl-5alpha-cholesta-8,24-dien-3beta-ol (T-MAS). Based on consistent yields of approximately 5 mug of FF-MAS per mL of culture, fermentation of genetically modified yeast compares favorably with other approaches to produce MAS.
Xu
Ran
R
Department of Chemistry, Rice University, Houston, Texas 77005, USA.
Wilson
William K
WK
Matsuda
Seiichi P T
SP
D002775:Cholestadienols / Q000378:metabolism*; D002782:Cholestenes / Q000378:metabolism*; D005818:Genetic Engineering / Q000379:methods; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism*; D013261:Sterols / Q000096:biosynthesis*
D002775:Cholestadienols; D002782:Cholestenes; D013261:Sterols; C071868:4,4-dimethylcholesta-8,14-dien-3-ol; C100324:4,4-dimethylcholesta-8,14,24-trienol